[1]
|
Segal, J.P., LeBlanc, J. and Hart, A.L. (2021) Ulcerative Colitis: An Update. Clinical Medicine, 21, 135-139. https://doi.org/10.7861/clinmed.2021-0080
|
[2]
|
Khrom, M., Long, M., Dube, S., Robbins, L., Botwin, G.J., Yang, S., et al. (2024) Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Gastroenterology, 167, 315-332. https://doi.org/10.1053/j.gastro.2024.02.026
|
[3]
|
丁香玉, 李承新. 消化系统疾病的皮肤表现综述[J]. 解放军医学院学报, 2022, 43(1): 106-109.
|
[4]
|
Maverakis, E., Marzano, A.V., Le, S.T., Callen, J.P., Brüggen, M., Guenova, E., et al. (2020) Pyoderma Gangrenosum. Nature Reviews Disease Primers, 6, Article No. 81. https://doi.org/10.1038/s41572-020-0213-x
|
[5]
|
Plumptre, I., Knabel, D. and Tomecki, K. (2018) Pyoderma Gangrenosum: A Review for the Gastroenterologist. Inflammatory Bowel Diseases, 24, 2510-2517. https://doi.org/10.1093/ibd/izy174
|
[6]
|
Vornehm, N.D., Kelley, S.R. and Ellis, B.J. (2011) Parastomal Small Bowel Evisceration as a Result of Parastomal Pyoderma Gangrenosum in a Patient with Crohn’s Disease. The American Surgeon, 77, E150-E151.
|
[7]
|
Marzano, A.V., Fanoni, D., Antiga, E., Quaglino, P., Caproni, M., Crosti, C., et al. (2014) Expression of Cytokines, Chemokines and Other Effector Molecules in Two Prototypic Autoinflammatory Skin Diseases, Pyoderma Gangrenosum and Sweet’s Syndrome. Clinical and Experimental Immunology, 178, 48-56.
|
[8]
|
杨秋碧, 周晓鸿, 秦帆, 等. 坏疽性脓皮病的发病机制及治疗进展[J]. 皮肤病与性病, 2024, 46(1): 19-23.
|
[9]
|
Wollina, U. (2007) Pyoderma Gangrenosum—A Review. Orphanet Journal of Rare Diseases, 2, Article No. 19. https://doi.org/10.1186/1750-1172-2-19
|
[10]
|
Su, W.P.D., Davis, M.D.P., Weenig, R.H., Powell, F.C. and Perry, H.O. (2004) Pyoderma Gangrenosum: Clinicopathologic Correlation and Proposed Diagnostic Criteria. International Journal of Dermatology, 43, 790-800. https://doi.org/10.1111/j.1365-4632.2004.02128.x
|
[11]
|
Jockenhöfer, F., Wollina, U., Salva, K.A., Benson, S. and Dissemond, J. (2018) The PARACELSUS Score: A Novel Diagnostic Tool for Pyoderma Gangrenosum. British Journal of Dermatology, 180, 615-620. https://doi.org/10.1111/bjd.16401
|
[12]
|
Haag, C., Hansen, T., Hajar, T., Latour, E., Keller, J., Shinkai, K., et al. (2021) Comparison of Three Diagnostic Frameworks for Pyoderma Gangrenosum. Journal of Investigative Dermatology, 141, 59-63. https://doi.org/10.1016/j.jid.2020.04.019
|
[13]
|
Maverakis, E., Marzano, A.V., Le, S.T., Callen, J.P., Brüggen, M., Guenova, E., et al. (2020) Pyoderma Gangrenosum. Nature Reviews Disease Primers, 6, Article No. 81. https://doi.org/10.1038/s41572-020-0213-x
|
[14]
|
Ahronowitz, I., Harp, J. and Shinkai, K. (2012) Etiology and Management of Pyoderma Gangrenosum. American Journal of Clinical Dermatology, 13, 191-211. https://doi.org/10.2165/11595240-000000000-00000
|
[15]
|
Sassolas, B., le Ru, Y., Plantin, P., Lair, G., Dupre, P., Cochard, G., et al. (2000) Pyoderma Gangrenosum with Pathergic Phenomenon in Pregnancy. British Journal of Dermatology, 142, 827-828. https://doi.org/10.1046/j.1365-2133.2000.03444.x
|
[16]
|
Thomas, K.S., Ormerod, A.D., Craig, F.E., Greenlaw, N., Norrie, J., Mitchell, E., et al. (2016) Clinical Outcomes and Response of Patients Applying Topical Therapy for Pyoderma Gangrenosum: A Prospective Cohort Study. Journal of the American Academy of Dermatology, 75, 940-949. https://doi.org/10.1016/j.jaad.2016.06.016
|
[17]
|
Patel, F., Fitzmaurice, S., Duong, C., He, Y., Fergus, J., Raychaudhuri, S., et al. (2015) Effective Strategies for the Management of Pyoderma Gangrenosum: A Comprehensive Review. Acta Dermato Venereologica, 95, 525-531. https://doi.org/10.2340/00015555-2008
|
[18]
|
Gettler, S.L., Rothe, M.J., Grin, C. and Grant-Kels, J.M. (2003) Optimal Treatment of Pyoderma Gangrenosum. American Journal of Clinical Dermatology, 4, 597-608. https://doi.org/10.2165/00128071-200304090-00002
|
[19]
|
Westerdahl, J.S., Nusbaum, K.B., Chung, C.G., Kaffenberger, B.H. and Ortega-Loayza, A.G. (2021) Ustekinumab as Adjuvant Treatment for All Pyoderma Gangrenosum Subtypes. Journal of Dermatological Treatment, 33, 2386-2390. https://doi.org/10.1080/09546634.2021.1937475
|
[20]
|
Gameiro, A., Pereira, N., Cardoso, J.C. and Gonçalo, M. (2015) Pyoderma Gangrenosum: Challenges and Solutions. OncoTargets and Therapy, 8, 285-293. https://doi.org/10.2147/ott.s61202
|